﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2010v3.4">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2011-11-14T15:18:16-06:00</Timestamp>
    <TaxPeriodEndDate>2010-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>CLARK NUBER PS</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>10900 NE 4TH STREET SUITE 1700</AddressLine1>
        <City>BELLEVUE</City>
        <State>WA</State>
        <ZIPCode>98004</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2010-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>911608978</EIN>
      <Name>
        <BusinessNameLine1>INFECTIOUS DISEASE RESEARCH INSTITUTE</BusinessNameLine1>
      </Name>
      <NameControl>INFE</NameControl>
      <Phone>2065186267</Phone>
      <USAddress>
        <AddressLine1>1124 COLUMBIA STREET NO 400</AddressLine1>
        <City>SEATTLE</City>
        <State>WA</State>
        <ZIPCode>98104</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>STEWART PARKER</Name>
      <Title>CHIEF EXECUTIVE OFFICER</Title>
      <Phone>2065186267</Phone>
      <DateSigned>2011-11-14</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>JANE M SEARING</Name>
      <Phone>4254544919</Phone>
    </Preparer>
    <TaxYear>2010</TaxYear>
    <BuildTS>2016-03-07 17:11:31Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>STEWART PARKER</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>1124 COLUMBIA STREET NO 400</AddressLine1>
        <City>SEATTLE</City>
        <State>WA</State>
        <ZIPCode>98104</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>15698974</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.IDRI.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1993</YearFormation>
      <StateLegalDomicile>WA</StateLegalDomicile>
      <ActivityOrMissionDescription>DEVELOP VACCINES, DIAGNOSTICS &amp; DRUGS TO PREVENT, DETECT &amp; TREAT INFECTIOUS DISEASES OF POVERTY.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>9</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>8</NbrIndependentVotingMembers>
      <TotalNbrEmployees>113</TotalNbrEmployees>
      <TotalNbrVolunteers>9</TotalNbrVolunteers>
      <TotalGrossUBI>691965</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>-76055</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>6872037</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>11561223</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>1703530</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>2373753</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>216727</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>18026</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>1326291</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>606808</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>10118585</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>14559810</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>584966</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>0</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>7264064</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>7743408</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>0</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>139885</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>10656224</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>13860619</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>18505254</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>21604027</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>-8386669</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>-7044217</RevenuesLessExpensesCY>
      <TotalAssetsBOY>54279947</TotalAssetsBOY>
      <TotalAssetsEOY>48731045</TotalAssetsEOY>
      <TotalLiabilitiesBOY>2329585</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>3825404</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>51950362</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>44905641</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>DEVELOP VACCINES, DIAGNOSTICS AND NOVEL DRUGS TO PREVENT, DETECT AND TREAT INFECTIOUS DISEASES OF POVERTY.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>10877126</Expense>
      <Revenue>1318593</Revenue>
      <Description>VACCINE RESEARCH - VACCINES ARE COMPOSED OF SEVERAL COMPONENTS: (A) ANTIGENS THAT STIMULATE THE IMMUNE SYSTEM TO COMBAT A PARTICULAR INFECTIOUS DISEASE AND (B) ADJUVANTS, SUBSTANCES THAT ENHANCE THE ABILITY OF ANTIGENS TO STIMULATE THE BODY'S IMMUNE RESPONSE. PUT ANOTHER WAY, ANTIGENS DETERMINE THE SPECIFICITY OF THE IMMUNE RESPONSE (E.G., FOR INFLUENZA OR TETANUS) WHEREAS ADJUVANTS AFFECT THE MAGNITUDE OF THE BODY'S IMMUNE RESPONSE.IDRI'S SCIENTISTS ARE USING THE LATEST TECHNIQUES TO IDENTIFY THE BEST ANTIGENS FOR NEW VACCINES TO COMBAT DISEASES THAT IMPACT GLOBAL HEALTH. IDRI'S CANDIDATE VACCINE FOR LEISHMANIASIS IS CURRENTLY IN CLINICAL TESTING AND VACCINES FOR TUBERCULOSIS AND LEPROSY ARE POISED TO START CLINICAL TESTING.</Description>
      <Activity2>
        <Expense>5224269</Expense>
        <Revenue>635029</Revenue>
        <Description>ADJUVANT RESEARCH - AN IMPORTANT AREA OF RESEARCH FOR IDRI IS IMPROVING ADJUVANTS AND HOW THEY ARE COMBINED WITH ANTIGENS TO IMPROVE VACCINES. BETTER ADJUVANTS CAN INCREASE AND BROADEN THE IMMUNE RESPONSE TO AN ANTIGEN, AS WELL AS REDUCE THE AMOUNT OF ANTIGEN NECESSARY FOR A GOOD RESPONSE. THIS LAST CHARACTERISTIC CAN MAKE OUR VACCINE STOCKS GO FURTHER AND POTENTIALLY REDUCE THE COST. IDRI IS COLLABORATING WITH PARTNERS ALL OVER THE WORLD TO IMPROVE VACCINES FOR ADDITIONAL CHALLENGING DISEASES SUCH AS MALARIA AND PANDEMIC INFLUENZA.</Description>
      </Activity2>
      <Activity3>
        <Expense>2207697</Expense>
        <Revenue>264085</Revenue>
        <Description>TUBERCULOSIS DRUG DISCOVERY - IN ADDITION TO WORKING ON BETTER DIAGNOSTIC TESTS AND VACCINES FOR TUBERCULOSIS (TB), IDRI HAS AN EARLY DISCOVERY PROGRAM TO IDENTIFY NEW CHEMICAL COMPOUNDS THAT ARE CANDIDATES TO TREAT TB. THERE IS AN URGENT NEED FOR NEW TYPES OF TB DRUGS; THE ONES CURRENTLY USED WERE DEVELOPED OVER 40 YEARS AGO AND WE ARE FACED WITH AN INCREASING THREAT FROM BACTERIA THAT ARE RESISTANT TO MANY OF THESE DRUGS. THE DRUG DISCOVERY GROUP COMBINES THE SKILLS OF MICROBIOLOGISTS, CHEMISTS, AND MOLECULAR BIOLOGISTS AND COLLABORATES WITH PHARMACEUTICAL COMPANIES AND OTHER RESEARCH INSTITUTIONS TO MAXIMIZE OUR CHANCE OF SUCCESS.</Description>
      </Activity3>
      <ActivityOther>
        <Expense>24188</Expense>
        <Revenue>70555</Revenue>
        <Description>MANUFACTURING - ONCE A VACCINE CANDIDATE HAS BEEN IDENTIFIED IN THE RESEARCH LAB, THE NEXT CHALLENGE IS TO APPLY THAT DISCOVERY TO THE CLINICAL SETTING. A NECESSARY PART OF THIS TRANSITION IS TO PRODUCE VACCINES UNDER CONTROLLED CONDITIONS SO THAT THEY ARE SUITABLE FOR USE IN HUMAN STUDIES. IDRI HAS DEVELOPED THE TYPE OF MANUFACTURING CAPABILITY REQUIRED TO MOVE A VACCINE FROM LATE STAGE RESEARCH TO EARLY CLINICAL STUDIES.</Description>
      </ActivityOther>
      <ActivityOther>
        <Expense>325750</Expense>
        <Revenue>89010</Revenue>
        <Description>OTHER ACTIVITIES - IDRI'S CLINICAL GROUP DESIGNS AND CONDUCTS EARLY STAGE CLINICAL TRIALS TO TEST THE VACCINE CANDIDATES IDENTIFIED BY IDRI SCIENTISTS OR COLLABORATORS. THROUGH OUR NETWORK OF GLOBAL CONNECTIONS, THE CLINICAL TEAM IS ABLE TO LAUNCH CLINICAL TRIALS ALMOST ANYWHERE IN THE WORLD.</Description>
      </ActivityOther>
      <TotalOfOtherProgramServiceExp>349938</TotalOfOtherProgramServiceExp>
      <TotalOfOtherProgramServiceRev>159565</TotalOfOtherProgramServiceRev>
      <TotalProgramServiceExpense>18659030</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities referenceDocumentId="RetDoc1039700001">0</PoliticalActivities>
      <LobbyingActivities referenceDocumentId="RetDoc1039700001">1</LobbyingActivities>
      <SubjectToProxyTax referenceDocumentId="RetDoc1039700001">0</SubjectToProxyTax>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">0</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc1040000001">1</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc1040000001">0</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc1040000001">0</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc1040000001">0</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc1040000001">0</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities referenceDocumentId="RetDoc1040500001">1</ForeignActivities>
      <MoreThan5000KToOrganizations referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations>0</GrantsToOrganizations>
      <GrantsToIndividuals>0</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc1042400001">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP referenceDocumentId="RetDoc1042800001">0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization referenceDocumentId="RetDoc1042800001">0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember referenceDocumentId="RetDoc1042800001">0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp referenceDocumentId="RetDoc1042800001">1</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity>0</DisregardedEntity>
      <RelatedEntity>0</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransactionRelatedEntity>0</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg>0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership>0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>31</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>113</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>1</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>1</UnrelatedBusinessIncome>
      <Form990-TFiled>1</Form990-TFiled>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>9</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>8</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>0</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>WA</StatesWhereCopyOfReturnIsFiled>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NameBusiness>
          <BusinessNameLine1>THERESE COAD AND PATRICIA MIELE</BusinessNameLine1>
        </NameBusiness>
        <TelephoneNumber>2065186267</TelephoneNumber>
        <AddressUS>
          <AddressLine1>1124 COLUMBIA STREET SUITE 400</AddressLine1>
          <City>SEATTLE</City>
          <State>WA</State>
          <ZIPCode>98104</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>STEVEN REED</NamePerson>
        <Title>HEAD OF RESEARCH/DIRECTOR</Title>
        <AverageHoursPerWeek>20.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>61112</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>621</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ERIC EASOM</NamePerson>
        <Title>CHAIRMAN</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DAVID MAKI</NamePerson>
        <Title>TREASURER</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DAVID WEBSTER</NamePerson>
        <Title>VICE CHAIRMAN</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>14153</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>CHRISTOPHER EARL</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>CYNTHIA HEALY</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>CHRIS HENTSCHEL</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DAVID PERRY</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>FRANKLYN PRENDERGAST</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>2.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>CURTIS MALLOY</NamePerson>
        <Title>PRESIDENT</Title>
        <AverageHoursPerWeek>50.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>159282</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>19554</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>KAREN KINCH</NamePerson>
        <Title>VICE PRESIDENT</Title>
        <AverageHoursPerWeek>50.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>111651</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>14478</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ANNA MARIE BECKMANN</NamePerson>
        <Title>EMPLOYEE</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>135436</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>9467</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>RHEA COLER</NamePerson>
        <Title>EMPLOYEE</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>133087</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>5786</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>FRANCO PIAZZA</NamePerson>
        <Title>EMPLOYEE</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>220190</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>4819</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>TOM VEDVICK</NamePerson>
        <Title>EMPLOYEE</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>123455</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>14291</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>WINSTON WICOMB</NamePerson>
        <Title>EMPLOYEE</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>122259</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>19820</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>1080625</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>0</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>88836</TotalOtherCompensation>
      <NumberIndividualsGT100K>12</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>UNIVERSITY OF IOWA</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>2501 CROSSPARK ROAD</AddressLine1>
            <City>CORALVILLE</City>
            <State>IA</State>
            <ZIPCode>52241</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>RESEARCH</DescriptionOfServices>
        <Compensation>1035717</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>SNBL USA LTD</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>6605 MERRILL CREEK PKWY</AddressLine1>
            <City>EVERETT</City>
            <State>WA</State>
            <ZIPCode>98203</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>RESEARCH</DescriptionOfServices>
        <Compensation>344200</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>SEED INTELLECTUAL PROPERTY LAW GROUP PL</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>701 5TH AVE SUITE 5400</AddressLine1>
            <City>SEATTLE</City>
            <State>WA</State>
            <ZIPCode>98104</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>LEGAL</DescriptionOfServices>
        <Compensation>300304</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>DHARMA THERAPEUTICS</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>1124 COLUMBIA</AddressLine1>
            <City>SEATTLE</City>
            <State>WA</State>
            <ZIPCode>98104</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>RESEARCH</DescriptionOfServices>
        <Compensation>269395</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>CHEMBIO DIAGNOSTIC SYSTEM INC</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>3661 HORSEBLOCK ROAD</AddressLine1>
            <City>MEDFORD</City>
            <State>NY</State>
            <ZIPCode>11763</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>RESEARCH</DescriptionOfServices>
        <Compensation>202506</Compensation>
      </ContractorCompensation>
      <NumberOfContractorsGT100K>9</NumberOfContractorsGT100K>
      <GovernmentGrants>6244455</GovernmentGrants>
      <AllOtherContributions>5316768</AllOtherContributions>
      <TotalContributions>11561223</TotalContributions>
      <ProgramServiceRevenue>
        <Description>CONTRACT REVENUE</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>1087360</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>1087360</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>VIVARIUM INCOME</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>641135</TotalRevenueColumn>
        <UnrelatedBusinessRevenue>641135</UnrelatedBusinessRevenue>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>LICENSING REVENUE</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>470000</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>470000</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>RESEARCH REVENUE</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>90652</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>90652</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>IT SERVICES</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>21270</TotalRevenueColumn>
        <UnrelatedBusinessRevenue>21270</UnrelatedBusinessRevenue>
      </ProgramServiceRevenue>
      <TotalOthProgramServiceRevenue>
        <TotalRevenueColumn>63336</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>63336</RelatedOrExemptFunctionIncome>
      </TotalOthProgramServiceRevenue>
      <TotalProgramServiceRevenue>2373753</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>38890</TotalRevenueColumn>
        <ExclusionAmount>38890</ExclusionAmount>
      </InvestmentIncome>
      <RoyaltiesRevenue>
        <TotalRevenueColumn>160221</TotalRevenueColumn>
        <ExclusionAmount>160221</ExclusionAmount>
      </RoyaltiesRevenue>
      <GrossRents>
        <Real>1347179</Real>
        <Personal>29560</Personal>
      </GrossRents>
      <LessRentalExpenses>
        <Real>1118300</Real>
        <Personal>0</Personal>
      </LessRentalExpenses>
      <RentalIncomeOrLoss>
        <Real>228879</Real>
        <Personal>29560</Personal>
      </RentalIncomeOrLoss>
      <NetRentalIncomeOrLoss>
        <TotalRevenueColumn>258439</TotalRevenueColumn>
        <UnrelatedBusinessRevenue>29560</UnrelatedBusinessRevenue>
        <ExclusionAmount>228879</ExclusionAmount>
      </NetRentalIncomeOrLoss>
      <GrossAmountSalesAssets>
        <Other>0</Other>
      </GrossAmountSalesAssets>
      <LessCostOthBasisSalesExpenses>
        <Other>20864</Other>
      </LessCostOthBasisSalesExpenses>
      <GainOrLoss>
        <Other>-20864</Other>
      </GainOrLoss>
      <NetGainOrLossInvestments>
        <TotalRevenueColumn>-20864</TotalRevenueColumn>
        <ExclusionAmount>-20864</ExclusionAmount>
      </NetGainOrLossInvestments>
      <OtherRevenueMisc>
        <Description>PROPERTY TAX REFUND</Description>
        <BusinessCode>900099</BusinessCode>
        <TotalRevenueColumn>159210</TotalRevenueColumn>
        <ExclusionAmount>159210</ExclusionAmount>
      </OtherRevenueMisc>
      <OtherRevenueMisc>
        <Description>REIMBURSEMENTS</Description>
        <BusinessCode>900099</BusinessCode>
        <TotalRevenueColumn>25419</TotalRevenueColumn>
        <ExclusionAmount>25419</ExclusionAmount>
      </OtherRevenueMisc>
      <OtherRevenueMisc>
        <Description>ANTIGEN SALES</Description>
        <BusinessCode>900099</BusinessCode>
        <TotalRevenueColumn>3519</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>3519</RelatedOrExemptFunctionIncome>
      </OtherRevenueMisc>
      <TotalOtherRevenue>188148</TotalOtherRevenue>
      <TotalRevenue>
        <TotalRevenueColumn>14559810</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>1714867</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>691965</UnrelatedBusinessRevenue>
        <ExclusionAmount>591755</ExclusionAmount>
      </TotalRevenue>
      <CompCurrentOfficersDirectors>
        <Total>303454</Total>
        <ManagementAndGeneral>282029</ManagementAndGeneral>
        <Fundraising>21425</Fundraising>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>5997149</Total>
        <ProgramServices>5397835</ProgramServices>
        <ManagementAndGeneral>533885</ManagementAndGeneral>
        <Fundraising>65429</Fundraising>
      </OtherSalariesAndWages>
      <PensionPlanContributions>
        <Total>79420</Total>
        <ProgramServices>71076</ProgramServices>
        <ManagementAndGeneral>7415</ManagementAndGeneral>
        <Fundraising>929</Fundraising>
      </PensionPlanContributions>
      <OtherEmployeeBenefits>
        <Total>863300</Total>
        <ProgramServices>751790</ProgramServices>
        <ManagementAndGeneral>101340</ManagementAndGeneral>
        <Fundraising>10170</Fundraising>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>500085</Total>
        <ProgramServices>430073</ProgramServices>
        <ManagementAndGeneral>63011</ManagementAndGeneral>
        <Fundraising>7001</Fundraising>
      </PayrollTaxes>
      <FeesForServicesManagement>
        <Total>155010</Total>
        <ProgramServices>76771</ProgramServices>
        <ManagementAndGeneral>78239</ManagementAndGeneral>
      </FeesForServicesManagement>
      <FeesForServicesLegal>
        <Total>437843</Total>
        <ProgramServices>377813</ProgramServices>
        <ManagementAndGeneral>60030</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>259693</Total>
        <ManagementAndGeneral>259693</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <FeesForServicesLobbying>
        <Total>17293</Total>
        <ManagementAndGeneral>17293</ManagementAndGeneral>
      </FeesForServicesLobbying>
      <FeesForServicesOther>
        <Total>318200</Total>
        <ProgramServices>318200</ProgramServices>
      </FeesForServicesOther>
      <Advertising>
        <Total>17276</Total>
        <ManagementAndGeneral>17276</ManagementAndGeneral>
      </Advertising>
      <OfficeExpenses>
        <Total>132984</Total>
        <ProgramServices>81416</ProgramServices>
        <ManagementAndGeneral>51568</ManagementAndGeneral>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>122915</Total>
        <ProgramServices>34790</ProgramServices>
        <ManagementAndGeneral>88125</ManagementAndGeneral>
      </InformationTechnology>
      <Occupancy>
        <Total>2546552</Total>
        <ProgramServices>2199760</ProgramServices>
        <ManagementAndGeneral>323676</ManagementAndGeneral>
        <Fundraising>23116</Fundraising>
      </Occupancy>
      <Travel>
        <Total>167489</Total>
        <ProgramServices>134866</ProgramServices>
        <ManagementAndGeneral>32623</ManagementAndGeneral>
      </Travel>
      <ConferencesMeetings>
        <Total>19106</Total>
        <ProgramServices>14098</ProgramServices>
        <ManagementAndGeneral>5008</ManagementAndGeneral>
      </ConferencesMeetings>
      <DepreciationDepletion>
        <Total>843897</Total>
        <ProgramServices>725751</ProgramServices>
        <ManagementAndGeneral>106331</ManagementAndGeneral>
        <Fundraising>11815</Fundraising>
      </DepreciationDepletion>
      <Insurance>
        <Total>7650</Total>
        <ProgramServices>7650</ProgramServices>
      </Insurance>
      <OtherExpenses>
        <Description>LAB SUPPLIES</Description>
        <Total>4327315</Total>
        <ProgramServices>3815804</ProgramServices>
        <ManagementAndGeneral>511511</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>SUBCONTRACTS</Description>
        <Total>4074268</Total>
        <ProgramServices>4074268</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>REPAIRS AND MAINTENANCE</Description>
        <Total>136107</Total>
        <ProgramServices>136107</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>RECRUITING</Description>
        <Total>105784</Total>
        <ManagementAndGeneral>105784</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>STATE &amp; LOCAL TAXES</Description>
        <Total>101689</Total>
        <ManagementAndGeneral>101689</ManagementAndGeneral>
      </OtherExpenses>
      <AllOtherExpenses>
        <Total>69548</Total>
        <ProgramServices>10962</ProgramServices>
        <ManagementAndGeneral>58586</ManagementAndGeneral>
      </AllOtherExpenses>
      <TotalFunctionalExpenses>
        <Total>21604027</Total>
        <ProgramServices>18659030</ProgramServices>
        <ManagementAndGeneral>2805112</ManagementAndGeneral>
        <Fundraising>139885</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>1049367</BOY>
        <EOY>1012591</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>16214937</BOY>
        <EOY>18692910</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>33522179</BOY>
        <EOY>25590537</EOY>
      </PledgesAndGrantsReceivable>
      <AccountsReceivable>
        <EOY>605496</EOY>
      </AccountsReceivable>
      <OtherNotesLoansReceivableNet>
        <BOY>109676</BOY>
      </OtherNotesLoansReceivableNet>
      <PrepaidExpensesDeferredCharges>
        <BOY>122091</BOY>
        <EOY>132504</EOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>5085922</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>2966325</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>2684287</BOY>
        <EOY>2119597</EOY>
      </LandBuildingsEquipmentBasisNet>
      <InvestmentsOtherSecurities>
        <BOY>577410</BOY>
        <EOY>577410</EOY>
      </InvestmentsOtherSecurities>
      <TotalAssets>
        <BOY>54279947</BOY>
        <EOY>48731045</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>1529975</BOY>
        <EOY>2090001</EOY>
      </AccountsPayableAccruedExpenses>
      <DeferredRevenue>
        <BOY>365594</BOY>
        <EOY>1363900</EOY>
      </DeferredRevenue>
      <OtherLiabilities>
        <BOY>434016</BOY>
        <EOY>371503</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>2329585</BOY>
        <EOY>3825404</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>2335392</BOY>
        <EOY>3039070</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <BOY>49614970</BOY>
        <EOY>41866571</EOY>
      </TemporarilyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>51950362</BOY>
        <EOY>44905641</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>54279947</BOY>
        <EOY>48731045</EOY>
      </TotalLiabNetAssetsFundBalances>
      <InfoInScheduleOPartXI>X</InfoInScheduleOPartXI>
      <ReconcilationRevenueExpenses>-7044217</ReconcilationRevenueExpenses>
      <ReconcilationOtherChanges>-504</ReconcilationOtherChanges>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>1</AuditCommittee>
      <FinancialStatementSeparate>X</FinancialStatementSeparate>
      <FederalGrantAuditRequired>1</FederalGrantAuditRequired>
      <FederalGrantAuditPerformed>1</FederalGrantAuditPerformed>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <MedicalResearchOrg170b1Aiii>X</MedicalResearchOrg170b1Aiii>
      <HospitalNameAndAddress>
        <Name>
          <BusinessNameLine1>UNIVERSIDAD CENTRAL DE VENEZUELA</BusinessNameLine1>
        </Name>
        <City>CARACAS</City>
        <Country>VE</Country>
      </HospitalNameAndAddress>
      <HospitalNameAndAddress>
        <Name>
          <BusinessNameLine1>UNIVERSITY OF KHARTOUM</BusinessNameLine1>
        </Name>
        <City>KHARTOUM</City>
        <Country>SU</Country>
      </HospitalNameAndAddress>
      <HospitalNameAndAddress>
        <Name>
          <BusinessNameLine1>CASE WESTERN RESERVE UNIVERSITY</BusinessNameLine1>
        </Name>
        <City>CLEVELAND</City>
        <State>OH</State>
      </HospitalNameAndAddress>
      <HospitalNameAndAddress>
        <Name>
          <BusinessNameLine1>BANARAS HINDU UNIVERSITY</BusinessNameLine1>
        </Name>
        <City>VARANASI</City>
        <Country>IN</Country>
      </HospitalNameAndAddress>
      <HospitalNameAndAddress>
        <Name>
          <BusinessNameLine1>UNIVERSIDAD PERUANA CAGETANO HEREDIA</BusinessNameLine1>
        </Name>
        <City>LIMA</City>
        <Country>PE</Country>
      </HospitalNameAndAddress>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="RetDoc1039700001">
      <Volunteers>0</Volunteers>
      <PaidStaffOrManagement>0</PaidStaffOrManagement>
      <MediaAdvertisements>0</MediaAdvertisements>
      <MailingsMembers>0</MailingsMembers>
      <PublicationsOrBroadcast>0</PublicationsOrBroadcast>
      <GrantsOtherOrganizations>0</GrantsOtherOrganizations>
      <DirectContactLegislators>1</DirectContactLegislators>
      <DirectContactLegislatorsAmount>17293</DirectContactLegislatorsAmount>
      <RalliesDemonstrations>0</RalliesDemonstrations>
      <OtherActivities>0</OtherActivities>
      <TotalLobbyingExpendituresIIB>17293</TotalLobbyingExpendituresIIB>
      <NotDescribedIn501c3>0</NotDescribedIn501c3>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <LeaseholdImprovements>
        <OtherCostOrOtherBasis>492204</OtherCostOrOtherBasis>
        <Depreciation>375570</Depreciation>
        <BookValue>116634</BookValue>
      </LeaseholdImprovements>
      <Equipment>
        <OtherCostOrOtherBasis>4593718</OtherCostOrOtherBasis>
        <Depreciation>2590755</Depreciation>
        <BookValue>2002963</BookValue>
      </Equipment>
      <TotalOfBookValueLandBuildings>2119597</TotalOfBookValueLandBuildings>
      <OtherLiabilities>
        <Description>DEFERRED RENT</Description>
        <Amount>336120</Amount>
      </OtherLiabilities>
      <OtherLiabilities>
        <Description>DEPOSITS</Description>
        <Amount>35383</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>371503</TotalOfAmounts>
      <TotalRevenue>14559810</TotalRevenue>
      <TotalExpenses>21604027</TotalExpenses>
      <ExcessOrDeficitForYear>-7044217</ExcessOrDeficitForYear>
      <NetUnrealizedGLOnInvestments>-504</NetUnrealizedGLOnInvestments>
      <TotalAdjustments>-504</TotalAdjustments>
      <ExcessOrDeficitPerFS>-7044721</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>14351386</TotRevenueEtcAuditedFinclStmt>
      <NetUnrealizedGainsInvestments>-504</NetUnrealizedGainsInvestments>
      <RevenueNotRptdF990>-504</RevenueNotRptdF990>
      <RevenueSubtotal>14351890</RevenueSubtotal>
      <OtherRevenuesNotIncluded>207920</OtherRevenuesNotIncluded>
      <RevenueNotRptdOnFinStmt>207920</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>14559810</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>21396107</TotExpensesEtcAuditedFinclStmt>
      <OtherExpensesIncluded>-207920</OtherExpensesIncluded>
      <ExpensesNotRptdF990>-207920</ExpensesNotRptdF990>
      <ExpensesSubtotal>21604027</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>21604027</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>PART XII, LINE 4B - OTHER ADJUSTMENTS:</Identifier>
        <Explanation>NET RENTAL INCOME NOT INCLUDED IN REVENUES ON FINANCIALS 228,879. DISPOSAL OF FIXED ASSET NOT INCLUDED IN REVENUE ON FINANCIALS -20,959.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>PART XIII, LINE 2D - OTHER ADJUSTMENTS:</Identifier>
        <Explanation>NET RENTAL INCOME REPORTED WITH REVENUES ON TAX RETURN -228,879. DISPOSAL OF FIXED ASSET REPORTED WITH REVENUES ON TAX RETURN 20,959.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <AcctsActvsOutUSTable>
        <Region>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>RESEARCH</SpecificServicesProvided>
        <TotalExpenditures>419562</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>SOUTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>RESEARCH</SpecificServicesProvided>
        <TotalExpenditures>230066</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>NORTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>RESEARCH</SpecificServicesProvided>
        <TotalExpenditures>29810</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>MIDDLE EAST AND NORTH AFRICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>RESEARCH</SpecificServicesProvided>
        <TotalExpenditures>225000</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>SUB-SAHARAN AFRICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>RESEARCH</SpecificServicesProvided>
        <TotalExpenditures>301352</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <SubtotalNumberOfEmployees>0</SubtotalNumberOfEmployees>
      <ContNumberOfEmployees>0</ContNumberOfEmployees>
      <TotalNumberOfEmployees>0</TotalNumberOfEmployees>
      <SubtotalAmountSpent>1205790</SubtotalAmountSpent>
      <ContAmountSpent>0</ContAmountSpent>
      <TotalAmountSpent>1205790</TotalAmountSpent>
      <TransferToForeignCorp>0</TransferToForeignCorp>
      <InterestInForeignTrust>0</InterestInForeignTrust>
      <OwnForeignCorp>0</OwnForeignCorp>
      <PassiveForeignInvestCo>0</PassiveForeignInvestCo>
      <ForeignPartnership>0</ForeignPartnership>
      <BoycottCountries>0</BoycottCountries>
    </IRS990ScheduleF>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommittee>X</CompensationCommittee>
      <CompensationSurvey>X</CompensationSurvey>
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>CURTIS MALLOY</NamePerson>
        <BaseCompensationFilingOrg>159282</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>1437</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>18117</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>178836</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NamePerson>FRANCO PIAZZA</NamePerson>
        <BaseCompensationFilingOrg>220190</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>4021</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>798</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>225009</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NameBusiness>
            <BusinessNameLine1>IMMUNE DESIGN CORPORATION</BusinessNameLine1>
          </NameBusiness>
        </NameOfInterestedPerson>
        <Relationship>SEE PART V</Relationship>
        <AmountOfTransaction>1344343</AmountOfTransaction>
        <DescriptionOfTransaction>SEE PART V</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NameBusiness>
            <BusinessNameLine1>DHARMA THERAPEUTICS</BusinessNameLine1>
          </NameBusiness>
        </NameOfInterestedPerson>
        <Relationship>SEE PART V</Relationship>
        <AmountOfTransaction>269395</AmountOfTransaction>
        <DescriptionOfTransaction>SEE PART V</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NameBusiness>
            <BusinessNameLine1>DHARMA THERAPEUTICS</BusinessNameLine1>
          </NameBusiness>
        </NameOfInterestedPerson>
        <Relationship>SEE PART V</Relationship>
        <AmountOfTransaction>376852</AmountOfTransaction>
        <DescriptionOfTransaction>SEE PART V</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
      <Form990ScheduleLPartV>
        <Explanation>SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS:(A) NAME OF PERSON: IMMUNE DESIGN CORPORATION(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: BOARD MEMBER STEVEN REED IS THE VICE PRESIDENT FOR IMMUNE DESIGN CORP.(D) DESCRIPTION OF TRANSACTION: SUBCONTRACTOR REVENUES(A) NAME OF PERSON: DHARMA THERAPEUTICS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: BOARD MEMBER DAVID MAKI IS A BOARD MEMBER AT DHARMA THERAPEUTICS.(D) DESCRIPTION OF TRANSACTION: SUBCONTRACTOR EXPENSES(A) NAME OF PERSON: DHARMA THERAPEUTICS(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: BOARD MEMBER DAVID MAKI IS A BOARD MEMBER AT DHARMA THERAPEUTICS.(D) DESCRIPTION OF TRANSACTION: RENTAL INCOME RECEIVED</Explanation>
      </Form990ScheduleLPartV>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART 1, LINE 6:</ReturnReference>
        <Explanation>THERE WERE NINE VOLUNTEER BOARD MEMBERS DURING THE YEAR. BOARD MEMBERS PARTICIPATE IN STRATEGIC PLANNING, EXECUTIVE LEADERSHIP RECRUITMENT AND SELECTION, INTELLECTUAL PROPERTY STRATEGY, AND IDENTIFICATION OF INSTITUTIONAL LIABILITY. THEY COME FROM A VARIETY OF BACKGROUNDS AND DEMONSTRATE FINANCIAL EXPERTISE, REAL ESTATE LEASING/PURCHASING EXPERTISE, BIO-MEDICAL NOT-FOR-PROFIT EXPERTISE, AND AN UNDERSTANDING OF BUSINESS AND BIOTECH LICENSING.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>FORM 990, PART VI, SECTION B, LINE 11</Identifier>
        <Explanation>FOR THE YEAR ENDING 12/31/10, THE FORM 990 WILL BE PRESENTED IN DRAFT TO THE FINANCE/AUDIT COMMITTEE FOR THEIR REVIEW. AS WITH THE AUDIT, THE FINANCE/AUDIT COMMITTEE, ON BEHALF OF THE IDRI BOARD OF DIRECTORS, WILL APPROVE THE FORM 990 AND THE FORM 990-T PRIOR TO FILING WITH THE IRS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 12C</ReturnReference>
        <Explanation>EACH JANUARY, MEMBERS OF THE BOARD OF DIRECTORS ARE GIVEN A COPY OF THE "CONFLICT OF INTEREST POLICY". THEY ARE REQUIRED TO FILL IT OUT AND RETURN IT BY THE FIRST BOARD MEETING - USUALLY SOMETIME IN THE FIRST QUARTER. THE SENIOR VICE PRESIDENT OF OPERATIONS AND GENERAL COUNSEL REVIEWS THE QUESTIONNAIRES AND SUMMARIZES THE RESULTS. THE RESULTS ARE COMMUNICATED TO THE BOARD OF DIRECTORS. TO THE EXTENT THAT THERE ARE ANY CONFLICTS, THE MEMBER IS RECUSED FROM ANY DECISION MAKING THAT WOULD INCLUDE THE CONFLICT. WHEN THE OCCASION ARISES, THOSE MEMBERS ALSO REMIND THE GROUP (MANAGEMENT TEAM OR BOARD) THAT THERE IS A POTENTIAL CONFLICT WHEN SPECIFIC DISCUSSION TOPICS ARISE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 15</ReturnReference>
        <Explanation>THE BOARD CHAIR DOES AN ANNUAL REVIEW OF STEVE REED AND CURT MALLOY AND WORKS WITH THE HUMAN RESOURCES DEPARTMENT TO DETERMINE IF THE COMPENSATION IS ADEQUATE. IF AN ADJUSTMENT IS DEEMED NECESSARY, THE BOARD CHAIR CONVENES THE COMPENSATION COMMITTEE AND THE ADJUSTMENT IS ADDRESSED. THE BOARD CHAIR REPORTS BACK TO THE HUMAN RESOURCES DEPARTMENT WHO FOLLOWS THROUGH WITH THE COMMITTEE'S RECOMMENDATION.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 19</ReturnReference>
        <Explanation>WHEN IDRI RECEIVES REQUESTS TO SHARE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS, THE PRESIDENT REVIEWS THE REQUEST AND, IF WARRANTED, DISCUSSES THE REQUEST WITH THE IDRI FINANCE COMMITTEE OR OTHER RELEVANT GOVERNING COMMITTEES. SUCH REQUESTS ARE TAKEN VERY SERIOUSLY IN LIGHT OF OUR BELIEF THAT NON-PROFIT ORGANIZATIONS SHOULD BE AS TRANSPARENT AS POSSIBLE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>CHANGES IN NET ASSETS OR FUND BALANCES:</Identifier>
        <ReturnReference>FORM 990, PART XI, LINE 5:</ReturnReference>
        <Explanation>NET UNREALIZED LOSSES ON INVESTMENTS: -504.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
  </ReturnData>
</Return>